Echo Therapeutics (ECTE) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.23), $0.08 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $19.11 thousand versus the consensus estimate of $20 thousand.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Webull Corp (BULL) Tops Q2 EPS by 1c
- SentinelOne Inc (S) PT Raised to $28 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
